Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

Similar articles for PubMed (Select 23867524)

1.

Erythrocytes encapsulated with phenylalanine hydroxylase exhibit improved pharmacokinetics and lowered plasma phenylalanine levels in normal mice.

Yew NS, Dufour E, Przybylska M, Putelat J, Crawley C, Foster M, Gentry S, Reczek D, Kloss A, Meyzaud A, Horand F, Cheng SH, Godfrin Y.

Mol Genet Metab. 2013 Aug;109(4):339-44. doi: 10.1016/j.ymgme.2013.05.011. Epub 2013 Jul 16.

PMID:
23867524
2.

Hepatocytes from wild-type or heterozygous donors are equally effective in achieving successful therapeutic liver repopulation in murine phenylketonuria (PKU).

Hamman KJ, Winn SR, Harding CO.

Mol Genet Metab. 2011 Nov;104(3):235-40. doi: 10.1016/j.ymgme.2011.07.027. Epub 2011 Aug 4.

3.

Long-term correction of hyperphenylalaninemia by AAV-mediated gene transfer leads to behavioral recovery in phenylketonuria mice.

Mochizuki S, Mizukami H, Ogura T, Kure S, Ichinohe A, Kojima K, Matsubara Y, Kobayahi E, Okada T, Hoshika A, Ozawa K, Kume A.

Gene Ther. 2004 Jul;11(13):1081-6.

PMID:
15057263
4.

Long-term enzymatic and phenotypic correction in the phenylketonuria mouse model by adeno-associated virus vector-mediated gene transfer.

Oh HJ, Park ES, Kang S, Jo I, Jung SC.

Pediatr Res. 2004 Aug;56(2):278-84. Epub 2004 Jun 4.

PMID:
15181195
5.

Correction of murine PKU following AAV-mediated intramuscular expression of a complete phenylalanine hydroxylating system.

Ding Z, Harding CO, Rebuffat A, Elzaouk L, Wolff JA, Thöny B.

Mol Ther. 2008 Apr;16(4):673-81. doi: 10.1038/mt.2008.17. Epub 2008 Mar 11.

7.

New insights into tetrahydrobiopterin pharmacodynamics from Pah enu1/2, a mouse model for compound heterozygous tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency.

Lagler FB, Gersting SW, Zsifkovits C, Steinbacher A, Eichinger A, Danecka MK, Staudigl M, Fingerhut R, Glossmann H, Muntau AC.

Biochem Pharmacol. 2010 Nov 15;80(10):1563-71. doi: 10.1016/j.bcp.2010.07.042. Epub 2010 Aug 10.

PMID:
20705059
8.
9.

Characterization of transgenic mice with the expression of phenylalanine hydroxylase and GTP cyclohydrolase I in the skin.

Christensen R, Alhonen L, Wahlfors J, Jakobsen M, Jensen TG.

Exp Dermatol. 2005 Jul;14(7):535-42.

PMID:
15946242
10.

Low therapeutic threshold for hepatocyte replacement in murine phenylketonuria.

Hamman K, Clark H, Montini E, Al-Dhalimy M, Grompe M, Finegold M, Harding CO.

Mol Ther. 2005 Aug;12(2):337-44.

11.

Gene therapy for phenylketonuria.

Eisensmith RC, Woo SL.

Acta Paediatr Suppl. 1994 Dec;407:124-9. Review.

PMID:
7766948
12.
13.

Phenylketonuria in The Netherlands: 93% of the mutations are detected by single-strand conformation analysis.

van der Sijs-Bos CJ, Diepstraten CM, Juyn JA, Plaisier M, Giltay JC, van Spronsen FJ, Smit GP, Berger R, Smeitink JA, Poll-The BT, Ploos van Amstel JK.

Hum Hered. 1996 Jul-Aug;46(4):185-90.

PMID:
8807319
14.

Complete restoration of phenylalanine oxidation in phenylketonuria mouse by a self-complementary adeno-associated virus vector.

Yagi H, Ogura T, Mizukami H, Urabe M, Hamada H, Yoshikawa H, Ozawa K, Kume A.

J Gene Med. 2011 Feb;13(2):114-22. doi: 10.1002/jgm.1543.

PMID:
21322099
15.
16.
17.

Gene therapy for phenylketonuria: phenotypic correction in a genetically deficient mouse model by adenovirus-mediated hepatic gene transfer.

Fang B, Eisensmith RC, Li XH, Finegold MJ, Shedlovsky A, Dove W, Woo SL.

Gene Ther. 1994 Jul;1(4):247-54.

PMID:
7584088
18.

Complete correction of hyperphenylalaninemia following liver-directed, recombinant AAV2/8 vector-mediated gene therapy in murine phenylketonuria.

Harding CO, Gillingham MB, Hamman K, Clark H, Goebel-Daghighi E, Bird A, Koeberl DD.

Gene Ther. 2006 Mar;13(5):457-62.

20.

Reversal of metabolic and neurological symptoms of phenylketonuric mice treated with a PAH containing helper-dependent adenoviral vector.

Cerreto M, Mehdawy B, Ombrone D, Nisticò R, Ruoppolo M, Usiello A, Daniele A, Pastore L, Salvatore F.

Curr Gene Ther. 2012 Feb 1;12(1):48-56.

PMID:
22348550
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk